Issue 42, 2017
From the journal:

Dalton Transactions

Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents

Angela Casini, ORCID logo a   Chris Orvig ORCID logo b  and  João D. G. Correia ORCID logo *c  

* Corresponding authors

a School of Chemistry, Cardiff University, CF10 3AT, Cardiff, UK

b University of British Columbia, Vancouver, British Columbia, Canada

c C2TN, IST, Universidade de Lisboa, 2695-066 Bobadela LRS, Portugal
E-mail: jgalamba@ctn.tecnico.ulisboa.pt

Abstract

A graphical abstract is available for this content

Graphical abstract: Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/C7DT90181J
Article type
Editorial
Submitted
27 Leo 2017
Accepted
27 Leo 2017
First published
23 Mph 2017

Dalton Trans., 2017,46, 14433-14434

Permissions

Request permissions

Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents

A. Casini, C. Orvig and J. D. G. Correia, Dalton Trans., 2017, 46, 14433 DOI: 10.1039/C7DT90181J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements